<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03291340</url>
  </required_header>
  <id_info>
    <org_study_id>827852</org_study_id>
    <nct_id>NCT03291340</nct_id>
  </id_info>
  <brief_title>Determining the Impact of Shunting and CerebroVascular Reactivity on 7T MRI (DISCoVeR 7T MRI)</brief_title>
  <acronym>DISCoVeR</acronym>
  <official_title>A Pilot Cross-sectional Cohort Study of Right-to-left-shunt, Cerebrovascular Reactivity, Ischemic Infarct Burden on High Resolution MRI, and Cognitive Impairment in Elderly Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to use transcanial doppler (TCD) ultrasound to look for possible
      risk factors for ischemic brain injury. We will perform contrast TCD with agitated saline
      contrast to identify and contrast right-to-left shunt (RLS) and breath holding to assess
      cerebrovascular reactivity (CVR) in the elderly.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 26, 2017</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of right-to-left shunt on TCD</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of cerebrovascular reactivity on TCD</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of ischemic injury</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Location of ischemic injury</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of cognitive impairment</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of cognitive impairment</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Cognitively normal elderly</arm_group_label>
    <description>TCD agitated saline right-to-left shunt study TCD cerebrovascular reactivity study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cognitive impaired elderly</arm_group_label>
    <description>TCD agitated saline right-to-left shunt study TCD cerebrovascular reactivity study</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Only subjects that are enrolled in the NACC longitudinal cohort (Protocol 068200) will be
        eligible for this study. Subjects must also agree to participate in the ADCC
        high-resolution MRI sub-study to be eligible.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males and females â‰¥ 60 years of age.

          2. Fluent in English.

          3. Part of the NACC longitudinal cohort (Protocol #: 068200) of the PMC/ADCC with
             consensus conference designation of cognitively normal, Mild Cognitive Impairment, or
             probable/possible Alzheimer's disease.

          4. Has consented to participate in the ADCC high-resolution MRI sub-study.

          5. NACC longitudinal visit must be within 6 months of the TCD study and brain MRI study.

          6. Women: post-menopausal or surgically sterile.

          7. Willing and able to complete all required study procedures.

          8. Completed 6 grades of education.

          9. Geriatric Depression scale less than 6 (assessed within 6 months at the NACC
             longitudinal visit).

        Exclusion Criteria:

          1. Prior clinically symptomatic ischemic or hemorrhagic stroke.

          2. Inability to tolerate or contraindication to TCD study in the opinion of an
             investigator or treating physician.

          3. Any medical or psychological conditions that, in the opinion of the investigator,
             would compromise the subject's safety or successful participation in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nichole Gallatti</last_name>
    <phone>2153498651</phone>
    <email>nichole.gallatti@uphs.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nichole Gallatti</last_name>
      <phone>215-349-8651</phone>
      <email>nichole.gallatti@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Steven R Messe, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2017</study_first_submitted>
  <study_first_submitted_qc>September 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2017</study_first_posted>
  <last_update_submitted>November 27, 2017</last_update_submitted>
  <last_update_submitted_qc>November 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Steven Messe</investigator_full_name>
    <investigator_title>Associate Professor of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

